This paper discusses the principles of study design and related methodologic issues in environmental epidemiology. Emphasis is given to studies aimed at evaluating causal hypotheses regarding exposures to suspected health hazards. Following background sections on the quantitative objectives and methods of population-based research, we present the major types of observational designs used in environmental epidemiology: first, the three basic designs involving the individual as the unit of analysis (i.e., cohort, cross-sectional, and case-control studies) and a brief discussion of genetic studies for assessing gene-environment interactions; second, various ecologic designs involving the group or region as the unit of analysis. Ecologic designs are given special emphasis in this paper because of our lack of resources or inability to accurately measure environmental exposures in large numbers of individuals. The paper concludes with a section highlighting current design issues in environmental epidemiology and several recommendations for future work. -Environ Health Perspect 101 (Suppl 4): 23-38 (1993).
Introduction
The purpose ofthis artide is to discus the principles of study design and related methodologic issues in environmental epidemiology. The focus is on studies aimed at evaluating csal hypotheses ding eosu to spected health hazards. Because the intended audience for this document indudes scientists without formal training in epidemiology, parts of this article highlight basic principles of epidemiologic reerc Nevertheless, we also try to summarze comprehensively the current state of the art and make recommendations for future developments in study design. For more tensive trment of general research principles and methods in epidemiology, the interested reader should consult available textbooks in this area (1) (2) (3) (4) (5) (6) . More detailed exmples ofapplications in environmentl epidemiology may be found in severl other books, such as those edited by Leaverton (7) , Chiazze et al. (8) , Goldsmith (9) , and Kopfler and Craun (10 the effect of a given exposure on disease occurrence in a particular population.
Measures of disease frequency involve the occurrence of new cases or deaths (incidence/mortality) or the presence of existing cases (prevalence). In both applications, the number of cases is expressed relative to the size of the population from which the cases are identified. With incidence measures, this denominator is the (base) population at risk (i.e., individuals who are eligible to become cases). Thus, the base population of a study (or study base) is the group of all individuals who, if they developed the disease, would become cases in the study (3, 11, 12) .
Disease incidence, which is central to the process of causal inference, can be expressed as a cumulative measure (risk) or as a person-time measure (rate). The cumulative incidence (incidence proportion) or average risk in a base population is the probability of someone in that population developing the disease during a specified period, conditional on not dying first from another disease (13) . The term cumulative incidence or cumulative incidence rate also is defined somewhat differently as the integral over the follow-up period of the hazard (rate) function (14) . The incidence rate or instantaneous risk (hazard) is the limit of the average risk for a given period, per unit of time, as the duration of the period approaches zero. The average rate (incidence density) for a given period is estimated as the number of incident events divided by the amount of person-time experienced by the base population. For example, a rate of 0.001/year means that we would expect one new case to occur for every 1000 person-years of followup (e.g., 100 disease-free people followed for an average of 10 years).
Although there are many quantitative methods for expressing the magnitude of a statistical association between two variables (e.g., exposure status and disease occurrence), we are usually interested in a special class of such measures that reflect the net effect of the exposure on disease occurrence (i.e., causal parameters). In general, a causal parameter for a target population is a hypothetical contrast-in the form of a difference or ratio-between what the frequency of disease would be if everyone were exposed (at a given level) to what the frequency would be if everyone were unexposed (often called the reference level) (15) . When this difference for a specific exposure is not zero (the ratio is not one), we say that the exposure is a risk factor for that disease in the target population. In practice, we estimate causal parameters indirectly by comparing disease frequency for an exposed group with disease frequency for an unexposed group. Epidemiologists typically estimate the risk or rate ratio (often called the relative risk) by comparing the exposed population with an unexposed population. The key assumption of this statistical approach is that the risk or rate observed for the unexposed group is the same (within confounder strata) as the risk or rate that would have been observed in the exposed group if that group had not been exposed (16) . Thus, the (true) risk ratio may be interpreted as a causal parameter, which is the number of cases actually occurring in the exposed (target) population divided by the number of cases that would have occurred in the absence of exposure.
Certain measures of association, such as correlation coefficients and standardized regression coefficients, do not, in general, reflect any causal parameters. The reason is that the magnitude of these measures depends in part on the relative variances of the exposure and disease variables, which are influenced by the sampling strategy (i.e., noncausal parameters) (17, 18) . Another measure of association, the odds ratio, is used in certain types of epidemiologic studies (case-control designs) to estimate the risk or rate ratio indirectly when we cannot first estimate the incidence rate or risk in the exposed and unexposed populations 20) .
Problems in Environmental Epidemiology
There are several general problems in environmental epidemiology that tend to limit causal inference and, therefore, shape design decisions.
Long Latent Periods. The interval between first exposure to an environmental risk factor (or the start of causal action of this factor) and disease detection (or symptom onset) may be many years or even decades.
Such long latent periods are pardy due to limitations ofmedical technology and incomplete surveillance for detecting disease; yet they are also due to a prolonged induction period in which years are needed for the disease process to begin (5) . The term latent period also is used more specifically to indicate the hypothetical interval between disease initiation and detection (5) . Refer also to Armenian and Lilienfeld (21) who discuss altemative definitions of latency. Unfortunately, long latent periods produce important practical constraints on our ability to estimate exposure effects. The investigator must either observe subjects for many years or rely on retrospective (historical) measurement of key variables. The latter altemative may be infeasible for certain types of exposures or in certain populations. Even when feasible, however, retrospective measurement usually increases the amount of error with which exposures are measured (see below). Furthermore, the level of most environmental exposures and many extraneous risk factors changes appreciably or unpredictably over time; long latent periods, therefore, seriously complicate our ability to estimate effects (22) .
Errors ofExposure Measurement. A major challenge in environmental epidemiology is to measure accurately each individual's exposure to hypothesized risk factors (i.e., the biologically relevant dose [ Thomas and Hatch, this issue] ). This task is made very difficult by the lack of information about environmental sources of emission, the complex pattern of most long-term exposures, the individual's ignorance of previous opportunities for exposure, the lack of good biological indicators of exposure level, and the lack of sufficient resources to collect individual exposure data on large populations. The consequences of exposure mismeasurement are probable bias in the estimation of effect (see "Sources of Epidemiologic Bias") and possible loss ofprecision and power with which effects are estimated and tested (23, 24) . The problem and issues of exposure measurement are discussed more thoroughly by Hatch and Thomas in this issue.
Rare Diseases, Low-Level Exposures, and Small Effects. In most epidemiologic studies of environmental hazards, statistical objectives may be further compromised by the infrequent occurrence of the disease or outcome of interest, by the low prevalence or levels of environmental exposures in the general population, and by the search for small effects (for which the true rate ratio is between 0.5 and 2). A critical consequence of these features is usually substantial loss of precision and power with which effects are estimated and tested. In addition, it becomes more difficult for the investigator to separate the effect of the exposure of interest from the distorting effects of extraneous factors. Causal 
Source ofEpidemiologic Bias
A common framework for describing the validity of epidemiologic research is to consider three sources of bias in the estimation of effect: selection bias, information bias, and confounding (2) . Despite the practical attractiveness of this framework, the three types of bias are not entirely separate concepts. The amount of confounding, for example, can depend on how subjects are selected.
Selection Bias. Selection bias means that the way in which subjects are selected into the study population or into the analysis (due to lost subjects or missing data) distorts the effect estimate. In general, this problem occurs when either disease status or exposure status influences the selection of subjects to a different extent in the groups being compared. Selection bias is most likely to be problematic when the investigator does not identify the base population from which study cases arose.
Information Bias. Information bias means that the nature or quality of measurement or data collection distorts the effect estimate. The primary source of information bias is error in measuring one or more variables. When exposure status or disease status is misclassified, bias usually occurs. If the probabilities of misclassification of each variable are the same for each category of the other variable (nondifferential misclassification) and if the errors for different variables are independent, the estimate of effect is usually biased toward the null value (indicating no effect). Possible exceptions to this principle of nondifferential misclassification leading to conservative effect estimates arise when the misclassified exposure variable is categorized into more than two groups (25) . In other situations involving differential misclassification (unequal misclassification probabilities) or correlated measurement errors, the effect estimate may be biased in either direction. In many studies, therefore, the magnitude of misclassification bias is difficult to predict, especially when other biases are operating.
Confounding. Confounding refers to a lack of comparability between exposure groups (e.g., exposed versus unexposed) such that disease risk would be different even if the exposure were absent or the same in both populations (16 (27) .
Experiments. In a simple experiment, there are usually two treatment groups. One group is assigned to receive the new experimental intervention and the other (control) group is assigned to receive no intervention, a sham intervention (placebo), or another available intervention. Simple randomization of individuals to treatment groups implies that all possible allocation schemes of assigned subjects are equally likely (28) . Following randomization, the investigator follows subjects for subsequent disease occurrence or change in outcome status. A comparison of risks between treatment groups provides an estimate of a causal parameter reflecting the treatment effect.
Because experiments are best suited ethically and practically to the study of health benefits, not hazards, experiments in environmental epidemiology would usually be limited to the study of preventive interventions. Furthermore, it is generally impossible or infeasible to randomize subjects individually. The only practical alternative, therefore, is to randomize by group, where the group might be a city, school, work site, etc. (29) . The major limitation of group randomization is some within-group dependence (correlation) of the outcome variable, which reduces precision and power (30, 31) . Thus, the effective sample size falls between the number of randomized groups and the total number of subjects (see Prentice and Thomas, this issue) .
As an example, consider the hypothesis that the intake of fluoride ions in drinking water has a protective effect on the occurrence of dental caries in children. An experiment might be conducted by randomly assigning many water districts (each with one fluoride-deficient water supply without treatment) either to implement sodium fluoride treatment under the control of the investigators or to continue its current policy of no treatment for the duration of follow-up. Assuming the hypothesis were true, we would expect the subsequent incidence rate of dental caries to be lower in the treated districts than in the untreated districts.
Randomization insures a valid comparison of subjects according to intended treatment, i.e., assigned treatment, but not according to treatment actually received (16;28 Strengths of a Cohort Design. The prospective cohort study is the observational design that is most similar to an experiment. The major strengths of this design derive from the fact that disease occurs and is detected after subjects are selected and after exposure status is measured. Thus, we can usually be confident that the exposure preceded the disease (i.e., there is no temporal ambiguity). This feature is particularly important when disease can also influence exposure status (e.g., persons with asthma moving to drier, lesspolluted areas). Well-designed retrospective cohort studies also lack temporal ambiguity of cause and effect.
Another major strength of the cohort design is the usual lack of selection bias that threatens other basic designs (2) . Disease status cannot, in principle, influence the selection of subjects except, perhaps, in poorly designed retrospective cohort studies. Sometimes researchers, ignoring this principle, propose random sampling to reduce bias. In fact, random sampling in a cohort study, unlike random assignment, does not prevent or necessarily reduce epidemiologic bias in effect estimation; i.e., random sampling generally does not improve comparability between exposure groups. It does, however, make the study population representative of a larger ,well-defined source population (sampling frame), which may make one's findings more generalizable. For example, suppose we initiated a prospective cohort study of lung cancer by mailing questionnaires to a random sample of 500,000 adults living in a given region served by population cancer registries. The questionnaire would request information on previous cancer diagnoses, exposure variables, and other risk factors for lung cancer. Following responses by 100,000 selected residents, the cancer registries would be used to identify all new cases of lung cancer diagnosed among respondents during the subsequent 5 years. Even though the 100,000 respondents will differ in many ways from the 400,000 nonrespondents, these differences will not cause epidemiologic bias in effect estimation. Nevertheless, the exposure effect observed for respondents (the base population) may not be generalizable to the population of nonrespondents. One possible reason for this lack of generalizability is that respondents and nonrespondents differ on the joint distribution of one or more effect modifiers.
As we will see in the next two sections, the same level of nonresponse in a crosssectional or case-control study that we assumed in the above cohort example might seriously threaten the validity of effect estimation. Thus, unlike cohort (or randomized) studies, nonresponse in other basic designs can easily introduce selection bias because study cases have already occurred when subjects are selected. As noted in "Sources of Epidemiologic Bias," selection bias is most likely to be problematic when the investigator does not identify the base population from which study cases arose (as in cross-sectional studies and certain case-control studies).
Weaknesses of a Cohort Design. A potential weakness of cohort designs is the loss of subjects to follow-up due to death from other diseases, lack of participation, or migration. Unlike subject selection, loss to follow-up can easily bias effect estimation if attrition is associated with disease risk to a different extent for exposed and unexposed groups (2, 35) . Unfortunately, we can neither rule out nor confirm such bias by comparing lost subjects and followed subjects with respect to baseline characteristics (including risk factors) (35) .
At best, baseline similarities between lost and followed subjects only suggest that loss to follow-up is probably not a major threat to validity, especially ifthe attrition rate is low.
Perhaps the major practical limitation of a cohort design, especially prospective studies, is its inefficiency for studying rare outcome events, which is what most diseases are in nonclinical populations. Because exposure status and other covariates must be observed at the start of follow-up in the entire study population, a rare disease would mean that most subjects will remain noncases. Comparing a small number of cases with a large number of noncases is statistically and economically inefficient because of the diminishing marginal return from additional noncases. Assuming a fixed sample size, therefore, it is more efficient to study a disease with an expected risk of 30% than to study a disease with an expected risk of 1%; the former will result in more precision and power for estimating and testing the exposure effect. Moreover, substantial increases in the sample size to compensate for too few expected cases is often impractical or impossible, especially when the size of the exposed population available for study is limited.
Time-Dependent Exposures. In conventional analyses of cohort-study data, exposure status and other covariates are usually treated as fixed variables measured at baseline. Yet the instantaneous and cumulative level of most environmental exposures changes during the follow-up period. Consequently, the greater the change and the longer the followup, the less appropriate are conventional methods of analysis. A common solution to this problem is to measure average exposure, duration of exposure, or cumulative exposure before and during the follow-up period; then these variables are analyzed like the simple baseline exposure variable, as possible (fixed) predictors of disease occurrence. Unfortunately, this approach also has methodologic problems: a) if the follow-up period for detecting disease overlaps the period during which exposure change is measured, the temporal relationship of an exposure-disease association is ambiguous. We may not know whether exposure changes preceded disease occurrence or disease preceded changes in exposure level. b) If the levels of exposure and/or other risk factors change over time, the associations between the exposure and these covariates also can change; then the amount of confounding of the estimated exposure effect will change. The analytic method described above, therefore, will not, in general, eliminate confounding due to these risk factors (even when there is no misdassification A statistical solution to the above problems was recently developed by Robins (36, 37) who treats the prolonged or changing predictor variables as time-dependent covariates for which repeated observations are collected during the follow-up. The method involves estimating causal parameters for hypothetical exposure experiences of the study population (15) . For example, we might want to compare the outcome risk for all subjects had they remained exposed throughout follow-up with these subjects had they remained unexposed, controlling for confounders at the start of each interval (time stratum). Cros-Secton Study A cross-sectional design involves a single ascertainment of disease prevalence in a study population that is usually sampled randomly from a single source population. In this sense, the source population is that larger group of individuals who are designated by the investigator as being eligible for inclusion in the study. Generally, in a cross-sectional study, we do not know how long prevalent (existing) cases have had the disease, nor can we identify the base population (at risk) from which the study cases arose. Exposure data on time-dependent variables are usually measured retrospectively to allow for expected variations in disease latency (before detection) and duration of expression (after detection).
The statistical analysis of cross-sectional data typically resembles the analysis of cohort or case-control data. Instead of comparing disease risks for exposed and unexposed groups, we compare disease prevalences (P), as in a cohort study, or we compare the prevalence odds (P/(1-P)), as in a case-control study (see "Case-Control Study"). Under certain conditions or assumptions, the prevalence ratio or prevalence odds ratio is approximately equal to the ratio of incidence rates or risks (i.e., the causal parameter of interest) (2, 38) . For example, disease prevalence in a population is a function of both incidence and the duration of disease. If the mean duration of disease (from onset to recovery or death) is known to be identical for exposed and unexposed cases, we can be more confident that the prevalence odds ratio approximates the incidence rate ratio.
Example. Suppose we want to estimate the possible effect of prenatal exposure to passive smoke (as in "Cohort Study") on birth weight, categorized for convenience into low (<2500 g) and normal. We identify all live births delivered in one hospital during a given period (the source population); then we take a random or quasi-random sample (e.g., every third birth). By obtaining exposure data retrospectively from mothers near the time of delivery, we can compare the prevalence of low birth weight for infants prenatally exposed and unexposed to passive smoke, controlling analytically for confounders (e.g., maternal age, maternal smoking, and prenatal care).
Even though births may be regarded as incident events, the infant's weight at birth is a prevalence measure, because we do not know the size of the base population. The causal parameter ofinterest is a hypothetical comparison of retarded development between fetuses exposed to passive smoke and those fetuses had they not been exposed. Not only can we not observe this hypothetical condition of exposed fetuses being unexposed, but we do not (or cannot) follow the base population; the prevalence of low birth weight is simply the end result ofthat hypothetical follow-up.
Strengths ofa Cross-Sectional Design. Because there is no follow-up, cross-sectional studies are less time-consuming and costly than prospective cohort studies. It is also feasible to examine many exposures and diseases in the same study, which makes this design useful for screening new hypotheses. In addition to causal inference, cross-sectional studies are important descriptively in health administration, planning, and policy analysis; information on disease prevalence is often required to assess the need and demand for health services and to evaluate intervention programs in specific target populations (2 When cross-sectional studies are conducted without random sampling, they offer little opportunity for making statistical inferences about descriptive, population-specific parameters, e.g., the prevalence of a disease in a specified source population (28) . The lack of random sampling may also worsen the potential problem of selection bias in effect estimation, which would be difficult to rule out a priori or to correct in the analysis. Even with random sampling, however, disease status or exposure status can influence the selection of subjects differentially by category of the other variable. For example, exposed cases may be less likely than others to be selected for study, perhaps because new exposed cases are less likely to survive than new unexposed cases (i.e., selective survival) or because exposed cases are less likely to enter the specified source population such as a hospital (i.e., Berkson's bias) (2) . Similarly, selection bias can result from the differential participation of selected subjects (i.e., response bias).
Case-Control Study
Case-control studies are distinguished from other basic designs by their sampling strategy: The investigator selects only a fraction of noncases (controls) from the population from which the cases were identified (2, 3, 5, 34, 39) . Sometimes this population is not the true (primary) base population (out of necessity or convenience), and occasionally controls are assembled without regard for the identification of cases. The design may be longitudinal, involving incident cases, or cross-sectional, involving prevalent cases. In both types, the investigator establishes the ratio of controls to cases, which does not depend directly on the frequency of disease in the population. As (2, 4, 14) . The potential advantage of matching in the selection of subjects is that it allows the investigator to control for confounders more efficiently than if matching is not used (1) (2) (3) (4) (5) (6) . Yet In the conventional proportional mortality study, comparison deaths are all other causes of death occurring in the population.
The traditional method of analysis is to compute the PMR, which is the proportion of exposed deaths resulting from the index disease divided by the proportion of unexposed deaths resulting from the index disease (6) . Altematively, the data are analyzed as in a case-control study, the researcher computes the mortality odds ratio (46, 47) . An important advantage of the alternative approach is that the comparison (control) group might be selected to indude only those diseases thought to be unrelated to exposure status. This design strategy, which also should be used in a proportional morbidity study, can help reduce selection bias by making the comparison group more representative of the base population. Another advantage is that it allows use of the many analytic techniques developed for case-control studies (48, 49) .
Strengths of a Case-Control Design. The major advantage of the case-control design over other basic designs is its efficiency for studying rare diseases, especially diseases with long latent periods. A greater proportion of study costs for collecting exposure and covariate data can be devoted to cases rather than expending most available resources on noncases. Thus, given a fixed sample size, case-control sampling in a study of a rare disease enhances the precision and power for estimating and testing the exposure effect. In addition, some case-control studies, particularly proportional mortality designs, tend to be relatively inexpensive and feasible because they can be based on readily available data sources.
Weaknesses of a Case-Control Design. A key issue in the design of case-control studies is the method and procedures for selecting controls. Ideally, we would like to make each study population-based, such that every new case occurrence in a welldefined base population is immediately identified by the investigators and controls are sampled randomly from the base population. In practice, however, this goal is not so easily accomplished, especially when the base is a large, dynamic population that cannot be examined periodically. Even population surveillance and registry systems, when they exist, are likely to be very incomplete for many diseases, such as prostate cancer, Alzheimer's disease, and ischemic heart disease. If exposed cases are more likely or less likely to be detected or reported than unexposed cases, the resulting effect estimate will be biased. In a cohort study, this detection problem would manifest as differential disease misclassification bias; but in a case-control study, the detection problem produces a form of selection bias that might involve no disease misclassification in the total sample and, therefore, cannot be corrected after subject selection (50) . To prevent such detection bias, the investigator might select controls who, purportedly, underwent the same degree of medical surveillance as did study cases (51) (52) (53) (54) (55) (56) . The twostage design is also advantageous when the cost of obtaining covariate data is large relative to the cost of obtaining exposure and disease data or when covariate data are missing on a majority of subjects (52, 54) .
Case-Crossover Design. A standard crossover design is an experiment or quasiexperiment in which each subject receives both the experimental and control treatments at different times (i.e., each subject serves as his or her own control) (57) . Such designs are seldom used in environmental epidemiology because manipulation of treatment status (with or without randomization) is usually unethical or infeasible and because the outcome is usually a rare event. Recently, Maclure (58) proposed an observational analogue of the crossover study called the case-crossover design, which may be regarded as a special type of pairwise-matched, case-control study. This type of design can be used to estimate the possible transient effect of a brief exposure (e.g., coffee drinking) on the subsequent occurrence of a rare acute-onset disease (e.g., myocardial infarction) that is hypothesized to occur within a short time after exposure (i.e., during the effect period). All subjects are newly detected cases that serve as their own controls. That is, for each case, the observed odds of being exposed during the effect period (e.g., one hour before disease onset) is compared with the expected odds of being exposed during any random period of the same duration (assuming no exposure effect). which must be defined. In addition to space-time duster analyses, the investigators will probably want to compare the disease rate in the duster-area population with the rate in another population thought to be unexposed (retrospective cohort study), and they may conduct a population-based case-control study to identify risk factors for the disease. Multiple-Group Study. In a multiplegroup ecologic study, we assess the ecologic association between average exposure level or prevalence and the rate of disease among many groups or regions. This is the most frequently used ecologic design in environmental epidemiology. Studies are usually conducted by linking separate sources of data. For example, census and tumor-registry data might be combined to estimate cancer rates for all counties in a state; other state records or surveys might be used to estimate average exposure levels by county. Statistical methods for estimating exposure effects in multiple-group studies are discussed in "Interpretation of Results" and by Prentice and Thomas in this issue.
Hatch and Susser (71) conducted a multiple-group ecologic study to examine the association between background gamma radiation and childhood cancers between 1975 and 1985 in the region surrounding the Three Mile Island nuclear plant. Using data from a 1976 aerial survey, they estimated the average radiation level for each of 69 tracts in the study region. The results of their analyses showed a positive association between radiation level and the incidence ofchildhood cancers. The authors were cautious in making causal inferences, however, because the large effect observed for solid tumors, as well as leukemias, was not expected.
Time-Trend Study. In time-trend (or time-series) studies, we assess the ecologic association between change in average exposure level or prevalence and change in disease rate in one geographically defined population. The assessment may be done by simple graphical displays or by more formal statistical techniques (72) (73) (74) (75) . With either approach, however, the interpretation of findings is often complicated by two issues. First, changes in disease dassification and diagnostic criteria can produce very misleading results. Second, the latency of the disease with respect to the exposure of interest may be long, variable across cases, and/or unknown to the investigator; thus, employing an arbitrary or empirically defined lag between the two trends can also produce very misleading results (76 leukemia rates varied over time in each country, they found no convincing evidence that these changes were attributed to changes in fallout radiation.
Mixed Study. The mixed ecologic design combines the basic features of the multiple-group study and the time-trend study. The objective is to assess the ecologic association between change in average exposure level or prevalence and change in disease rate among many groups. Thus, two types of comparisons are made simultaneously: change over time within groups and differences among groups.
For example, Crawford et al. (78) evaluated the hypothesis that hard drinking water (i.e., water containing more calcium and magnesium ions) is a protective risk factor for cardiovascular disease (CVD). They compared the absolute change in CVD mortality rate between 1948 and 1964, by age and sex, in 83 British towns. The towns were divided into three groups: a) five had experienced increases in water hardness; b) six had experienced decreases, and c) 72 had experienced little or no change in water hardness. In all sex-age groups, especially for men, the authors found an inverse association between trends in water hardness and CVD mortality. In middle-aged men, for example, the increase in CVD mortality was less in towns that made their water harder than in towns that made their water softer.
Interpretaon ofResults
Statistical analysis in a multiple-group study usually involves fitting the data to a mathematical model (see Prentice and Thomas, this issue). The outcome variable is a function of the disease rate in each group; predictors indude the average exposure level or proportion exposed in each group plus other ecologic covariates, the effects of which the investigator wants to control. We show in "Control for Covariates" that these covariates need not be confounders (i.e., at the individual level within groups).
Results of the fitted model can be used to estimate the exposure effect, i.e., the same causal parameter we would like to have estimated had the study been conducted at the individual level (63, 79, 80) . For example, suppose the exposure variable is the proportion exposed in each group and there are no covariates. Assuming a linear model, we can use weighted leastsquares regression to estimate the slope (b) and intercept (a). The predicted disease rate in a group that is entirely exposed is then a + b(l) = a + b, and the predicted rate in a group that is entirely unexposed is a + b(O) = a; therefore, the estimated rate ratio is (a + b)la = 1 + bla. It is important to note that this estimation procedure implies extrapolating the results of the model to both extreme values of the exposure variable, either or both of which may lie well beyond the observed range. It is not surprising, therefore, that different model forms can lead to very different estimates of effect (81) . In fact, certain model assumptions may lead to rate-ratio estimates that are negative and thus meaningless.
Ecologic Bias
The use of ecologic data to estimate causal parameters has a major methodologic limitation, called the ecological fallacy (82) , aggregation bias (83) , cross-level bias (84) , and ecologic bias (85, 86) . Ecologic bias refers, in general, to the failure of ecologic estimates of effect to reflect the true effect at the individual level. Some of this bias may occur in individual-level studies of the same population, but some of it is due specifically to the aggregation of subjects into groups. More importantly, the magnitude of ecologic bias is likely to be more severe and less predictable than is individual-level bias in estimating the same effect (63, 81, 8687) . It is very possible, for example, that an ecologic analysis of a (true) positive risk factor would produce an apparently protective effect.
The underlying problem of ecologic bias may be regarded as a special form of information bias resulting from withingroup heterogeneity of exposure status, which is not captured in the analysis. For example, a positive linear relationship between proportion exposed and disease rate does not necessarily mean that exposed individuals are at greater risk for the disease than are unexposed individuals; rather, unexposed individuals may be at greater risk in groups containing proportionally more exposed individuals. The implication of this latter explanation is that an individual's group affiliation has an effect on disease occurrence that reflects more than just the individual's exposure status.
A mathematical understanding of ecologic bias was first provided for correlation coefficients by Robinson (88) and later extended to regression coefficients by Duncan et al. (89) . Nevertheless, the conditions for valid ecologic estimation and the relationship between ecologic bias and other methodologic issues are still not well understood. Because the results of ecologic analyses are often used to influence policy decisions, as well as to make causal inferences, it is important for researchers to appreciate the complexities ofecologic inference.
Sources ofEcologic Bias. Ecologic bias is often confused with confounding, perhaps because regional differences in disease rates can be due to variation in the distribution of extraneous risk factors across regions. To darify the confusion between these two concepts, Greenland and Morgenstem (86;87,90) show that ecologic bias can arise from three different sources.
Within-Group Confounding (At the Individual Level). The exposure effect may be confounded within groups (as described for nonecologic studies in "Sources of Epidemiologic Bias"). (85) , even when the effect modification is relatively weak and there is no confounding by group.
Taken together, the above principles imply that there will be no ecologic bias if the disease rate in the unexposed population and the exposure effect do not vary across groups and if there is no net confounding within groups. Unfortunately, it is very unlikely that all of these conditions will be met in one ecologic study. Although small departures from these conditions may result in substantial bias (81, 86) , it is also possible that there will be little or no bias in certain studies when one or more of these conditions are not met.
If every group were completely exposed or unexposed, there would be no ecologic bias attributable to confounding or effect modification by group. Indeed, if all covariates were measured at the individual level, such a study would not be an ecologic design. Thus, to reduce ecologic bias, we should select regions that minimize withinregion exposure variation and maximize between-region variation (63, 81) . One strategy for achieving these goals is to choose the smallest unit of analysis for which required data are available (e.g., census tracts or blocks). Unfortunately, certain data are seldom available at this level (e.g., personal behaviors and biomedical factors), and there is no guarantee that these smaller units are more homogeneous with respect to exposure status. Furthermore, use of smaller groups might increase the problem of migration between groups (see "Other Methodologic Problems").
Contol for Covariat
In a study conducted entirely at the individual level, an extraneous risk factor produces bias (confounding) in effect estimation only if it is associated with exposure status in the base population (see "Sources of Epidemiologic Bias"). In a multiple-group ecologic study, however, an extraneous risk factor can produce ecologic bias even if it is not associated with exposure status within regions (at the individual level) (86, 87, 90) . Such bias occurs typically because the ecologic association (across regions) between the exposure and risk factor produces confounding and/or modification of the exposure effect by group (see "Ecologic Bias"). Conversely, an extraneous risk factor that is a confounder within regions may not produce ecologic bias if the net within-group bias is zero (see "Ecologic Bias") or if the risk factor is ecologically uncorrelated with the exposure.
One method to control for extraneous risk factors in ecologic studies is to indude predictor terms for these risk factors in the model (e.g., the proportion of smokers or the mean family income in each region). Unfortunately, even when such covariate data are available for all regions, ecologic adjustment usually cannot be expected to remove completely the ecologic bias produced by these risk factors. In fact, it is possible for such ecologic adjustment to increase bias (86) .
The general conditions under which the ecologic control for extraneous risk factors either increases or decreases bias have not been delineated. Yet, under certain restrictive conditions, ecologic control for covariates will produce unbiased estimates of the exposure effect, provided there are no other sources of bias (e.g., outcome misdassification). If the effects of the exposure and the covariate on disease rate are exactly additive within every region (i.e., the rate difference for each variable is constant across levels of the other variable) and if the rate conditional on both predictors is exactly the same in every region, ecologic regression of disease rate on the mean exposure and covariate levels (i.e., multiple linear regression) will lead to unbiased estimates of both effects (83, 84) . Under these conditions, group affiliation does not confound or modify the exposure effect at the individual level. However, as shown by Greenland (81) , relatively minor deviations from perfect additivity (linearity) can lead to appreciable ecologic bias because ecologic rate ratios can be extremely sensitive to the choice of model form, in contrast to individual-level estimates. Furthermore, the two conditions noted above are only sufficient for no ecologic bias to occur; ecologic bias may be absent when either or both conditions are not met.
Richardson and Hemon (91) recently pointed out that there is another set of conditions for which ecologic control of covariates is possible. If a) the exposure and covariates are uncorrelated within regions, b) their effects on disease are multiplicative (i.e., the rate ratio for each variable is constant across levels of the other variable), and c) the rate conditional on both predictors is exactly the same in every region, then ecologic bias due to the covariates can be removed or largely reduced by including product terms in the linear model. Of course, such conditions are very difficult to verify in ecologic studies; if the exposure and covariates (other risk factors) are correlated within regions, the covariates will be confounders at the individual level and substantial ecologic bias can occur even with product terms in the model (81) .
When the data are not entirely ecologic (see "Ecologic Designs"), rate standardization is another method often employed to adjust for extraneous risk factors in ecologic studies. For example, if the age distribution is known for cases and for the base population in every region, we can mutually standardize the rate in every region to the age distribution ofa well-defined (standard) population (5); then we use the standardized rates as the outcome variable in the ecologic analysis. Unfortunately, this method does not always reduce ecologic bias due to the variables for which the rates are standardized; in fact, the result may be to increase bias appreciably (8692). Standardization can be expected to reduce ecologic bias only if all variables in the model (i.e., disease and all predictors) are mutually standardized for those other confounders (e.g., age) not included as predictors in the regression model. This method is often not feasible, for example, when the investigator does not know the age distribution of exposed and unexposed populations within every region.
Other Methodologic Prblems
In addition to ecologic bias and the related difficulties of controlling for extraneous risk factors, there are other methodologic problems with ecologic analysis, a few of which are addressed below.
Exposure Misclassification Bias. As noted in "Sources of Epidemiologic Bias," nondifferential misclassification of exposure status in individual-level studies nearly always results in bias toward the null value; e.g., the estimated rate ratio will be doser to one than is the true rate ratio. In multiplegroup ecologic studies, however, this principle does not hold when the exposure variable is formed from the aggregated observations of all individuals in each region (e.g., the proportion exposed). Brenner et al. (93) have shown that nondifferential misdassification of a binary exposure within groups usually leads to overestimation of the rate ratio (away from the null value) in ecologic studies, which can be severe. This apparent contradiction between ecologic and individuallevel studies can be understood by considering just two regions. Nondifferential exposure misdassiflcation in both regions will produce an estimated difference in exposure prevalence that is smaller than the true difference. Consequently, the estimated regression coefficient (slope) for the exposure variable in a linear ecologic model will be overestimated, leading to overestimation of the rate ratio. Ltde is known about the impact in ecologic studies ofwithin-group error in measuring continuous or multiple-category exposures.
Confounder Misclasifiation. In studies conducted at the individual level, misdasificaion ofa confounder, ifnondifferential with respect to exposure and disease, will usually reduce our ability to control for the confounder in the analysis (94, 95) . That is, adjustment will not completely eliminate the bias due to the confounder. In ecologic studies, however, nondifferential misclassification of a binary confounder within groups does not affect our ability to control for that confounder (96 (4, 101, 102) . We need more methodologic research in this area to provide guidelines for the measurement of specific exposures in particular types of populations. One approach that might be pursued with environmental exposures is to combine ecologic data with self-reported data on individual behaviors. For example, suppose we collect ecologic data on pesticide spraying and distribution throughout a large region. We could then obtain from subjects the location oftheir homes; the type and location of their work; their use ofdfinking water; and how often they swim, fish, and participate in other activities that would affect their exposure to pesticides in the region.
Frequently, an accurate method does exist for measuring an exposure, but the application of this method to all subjects in a population is prohibitively expensive or infeasible. In such cases, many investigators rely on less accurate methods for the total sample and use the more accurate method in a subsample of subjects. Assuming the accurate method is perfectly valid (i.e., the gold standard), the results of the validation substudy are used to quantify the amount of measurement error, which is then used in the total sample to correct for misdassification bias involving the imperfect measure of exposure. Some important issues need to be considered to make this approach advantageous. First Essentially, ecologic bias (aside from within-group bias) occurs because group affiliation or the average exposure level of the group affects disease occurrence independently of exposure status at the individual level (see "Ecological Bias"). The structural effects ofsuch ecologic variables, ifthey can be separated from other effects at the individual level, might be informative, rather than just a source of error. Thus, by induding both ecologic and individual-level predictors (possibly of the same exposure) in the analysis, we might enhance our understanding of disease occurrence. This type of contextual or multilevel analysis has been used extensively in social science research (105-108) but rarely in epidemiologic research (109) . In addition, if the effect of a risk factor is known from previous research, the results of an ecologic analysis involving that risk factor could be used to evaluate the potential or realized impact of a population intervention, which may not be completely estimable at the individual level (63) . A more profound understanding of ecologic bias, therefore, could yield benefits to other public-health research.
Gene-Environment Interactions. Because both genetic and environmental factors contribute to the etiology of most diseases, we would typically expect factors of each type to confound and/or modify the effect of the other. We know, for example, that a combination of both environmental/personal factors and genetic susceptibilities are sufficient for the development of certain diseases. Yet standard methods of epidemiologic research and population genetics have not been well integrated (110) . As indicated in "Ecological Bias," we need new methods for incorporating environmental variables in genetic (e.g., linkage) analyses of pedigree data. We also need to understand better the relationship between those parameters estimated in pedigree studies and the effect parameters estimated in standard epidemiologic studies; and we need to understand better how the estimates of gene-environment interactions in pedigree studies are biased by confounding, measurement error, and family selection (ascertainment). With this understanding, we can devise new methods to prevent or control bias. Analogously, the use of family data in standard epidemiologic designs (e.g., history of disease and/or its risk factors in relatives) requires further development in order to handie differences in family size and composition among subjects. With the recent advances in molecular genetics, the integration of epidemiology and population genetics is likely to become more important in the future.
Sample Size and Power. As noted in "Problems in Environmental Epidemiology," epidemiologic studies of environmental exposures often require large sample sizes to detect risk-factor effects with sufficiently small statistical error. To address this concern, researchers are usually expected to justify their proposed sample size by estimating the power of their study for testing one or more major hypotheses (i.e., the probability of detecting an association of at least a certain magnitude with a designated Type I error-alpha level typically set at 5%). This is a rather straightforward procedure when the power estimation is applied to two dichotomous variables (exposure and disease) (1, 4, 111) . Yet all observational studies require more complicated analyses to make causal inferences -e.g., to deal with polytomous, continuous, or time-dependent exposures; covariate adjustment; the assessment of interaction effects; matching; and other special design features. Although methods of power estimation do exist for many of these complicating features, they require additional specifications (assumptions) about which the investigator is not likely to have adequate information. Further development of these methods would be useful, therefore, to identify techniques that are both practical and informative in specific situations, including ecologic studies for which sample size requirements have received little attention.
One parameter the investigator must specify to justify the proposed sample size is the magnitude of effect expected in the data or the minimum effect regarded as important to detect. In the absence of previous epidemiologic studies involving similar exposure levels, the expected effect is generally specified rather arbitrarily (e.g., a 
